KV's Gestiva Reemerges With New Name, Makena, And A Long-Sought FDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Approval of the pre-term birth prevention therapy could pull KV Pharmaceutical back from the brink.